BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $516,000 | -34.5% | 400,000 | -46.7% | 0.04% | -64.8% |
Q3 2019 | $788,000 | -73.0% | 750,000 | +200.0% | 0.12% | -75.4% |
Q2 2017 | $2,920,000 | +18.3% | 250,000 | +25.0% | 0.50% | +2.9% |
Q1 2017 | $2,468,000 | -47.4% | 200,000 | -13.6% | 0.48% | -29.8% |
Q4 2015 | $4,693,000 | +39.5% | 231,515 | +0.0% | 0.69% | +60.1% |
Q3 2015 | $3,364,000 | -31.7% | 231,514 | 0.0% | 0.43% | -11.0% |
Q2 2015 | $4,924,000 | -13.5% | 231,514 | -7.2% | 0.48% | -18.7% |
Q1 2015 | $5,693,000 | – | 249,567 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |